Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 33.20180.22-67.21-38.59-

What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?

The latest EBIT Growth ratio of PIRAMAL PHARMA is 33.20 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202533.20
Mar2024180.22
Mar2023-67.21
Mar2022-38.59
Mar2021-

How is EBIT Growth of PIRAMAL PHARMA Trending?

Years EBIT Growth % Change
Mar2025 33.2
-81.58
Mar2024 180.22
Positive
Mar2023 -67.21
Negative
Mar2022 -38.59
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EBIT Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,626.5 Cr 5.4% -5.6% -35.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,982.0 Cr -0.7% -0.5% -3.1% Stock Analytics
DIVIS LABORATORIES ₹172,878.0 Cr 2.8% 2.2% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,095.0 Cr 1.5% 3.4% 12.4% Stock Analytics
CIPLA ₹122,175.0 Cr 0.8% 0.1% 3.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,154.0 Cr 0.4% 3.2% 0.3% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

5.4%

-5.6%

-35.4%

SENSEX

0.4%

-0.1%

6.1%


You may also like the below Video Courses